英搏爾(300681.SZ):控股股東及其一致行動人已完成轉讓5%的股份予卓越智途
格隆匯6月7日丨英搏爾(300681.SZ)公佈,公司控股股東薑桂賓及其一致行動人李紅雨、魏標分別將其所持有的公司292.95萬股、56.7萬股、28.35萬股股份協議轉讓給珠海卓越智途股權投資管理中心(有限合夥)(“卓越智途”)的過户登記手續已辦理完畢,中國證券登記結算有限責任公司深圳分公司於2021年6月4日出具了《證券過户登記確認書》。

此次協議轉讓完成後,卓越智途持有公司378萬股股份,佔公司總股本的比例為5.00%,成為公司持股5%以上股份的股東,實現了公司管理層及核心人員等與公司發展利益協同的轉讓初衷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.